Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Notes underwriting agrmnt
Acq. announced
|
|
Jupiter Wellness, Inc. (JUPW)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2022 |
8-K
| Investor presentation |
| 12/29/2021 |
8-K
| Investor presentation|
Docs:
|
"Jupiter Wellness Issues Letter to Stockholders Dear Fellow Stockholders, Jupiter Wellness, Inc. , has, we believe, accomplished big things since it became publicly traded on November 1, 2020. Our definitive agreement to acquire Next Frontier Pharmaceuticals, Inc. , however, will, we believe, transform Jupiter into a leading pharmaceutical cannabinoid company with: ● One of four FDA approved cannabinoid drugs in the world – the only one approved in the United States and the only one based on Tetrahydrocannabinol ; ● Nine new drug indications in our clinical pipeline; ● A dozen patents issued and pending; ● A fully licensed and certified , 83,000 square foot synthetic cannabinoid manufacturing facility producing active pharmaceutical ingredients and with capacity to m..." |
|
|
|